MENAFN – Stamford, Conn., Oct. 22, 2024 – SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a biopharmaceutical company focused on rare diseases and cancer, will hold a live conference call and webcast on November 12, 2024, at 8:30 a.m. ET to discuss its third quarter financial results and business updates.
To join the webcast and view slides, please click here. You can also participate in the conference call by registering here. Registered participants will receive a dial-in number and conference code. A replay of the webcast will be available on the company’s website.
About SpringWorks Therapeutics
SpringWorks is a biopharmaceutical company focused on developing medicines for severe rare diseases and cancer. Their FDA-approved drug, OGSIVEO® (nirogacestat), treats adult patients with desmoid tumors. The company has a diverse pipeline targeting various cancers and collaborates with industry and academic innovators to enhance its offerings.
For more details, visit their website and follow @SpringWorksTx on social media.
Contacts:
Investors
…
Media
…
`
